Bristol Myers (BMY) Squibb announced positive data from the Phase 3 POETYK PsA-2 trial evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis. The POETYK PsA-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback